We are live on ! Find out more
Canada Life

Canada Life Portfolio holdings

AUM $55.8B
1-Year Est. Return 26.04%
This Fund
S&P 500
This Quarter Est. Return
+0.36%
1 Year Est. Return
+26.04%
3 Year Est. Return
+87.85%
5 Year Est. Return
+117.08%
10 Year Est. Return
+382.61%
AUM
$43B
AUM Growth
-$828M
Cap. Flow
-$850M
Cap. Flow %
-1.98%
Top 10 Hldgs %
20.7%
Holding
2,580
New
18
Increased
1,165
Reduced
580
Closed
42

Top Buys

Rank Stock Value
1
PATH icon
UiPath
PATH
+$25.5M
2
EA icon
Electronic Arts
EA
+$24.4M
3
SNOW icon
Snowflake
SNOW
+$21.9M
4
JCI icon
Johnson Controls International
JCI
+$20.1M
5
PLD icon
Prologis
PLD
+$19.8M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$218M
2
GE icon
GE Aerospace
GE
+$94.2M
3
CSCO icon
Cisco
CSCO
+$67M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$65.6M
5
MSFT icon
Microsoft
MSFT
+$48.9M

Sector Composition

Rank Sector Weight
1 Technology 26.24%
2 Financials 13.38%
3 Healthcare 12.87%
4 Consumer Discretionary 11.73%
5 Communication Services 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRIX icon
2401
Nurix Therapeutics
NRIX
$2.45B
$23K ﹤0.01%
772
-756
-49% -$23.3K
OFLX icon
2402
Omega Flex
OFLX
$292M
$23K ﹤0.01%
159
RNAM
2403
DELISTED
Avidity Biosciences
RNAM
$23K ﹤0.01%
930
TRUE
2404
DELISTED
TrueCar
TRUE
$23K ﹤0.01%
5,606
YORW icon
2405
York Water
YORW
$511M
$23K ﹤0.01%
517
KBAL
2406
DELISTED
Kimball International
KBAL
$23K ﹤0.01%
2,038
EPZM
2407
DELISTED
Epizyme, Inc
EPZM
$23K ﹤0.01%
4,505
PAE
2408
DELISTED
PAE Incorporated Class A Common Stock
PAE
$23K ﹤0.01%
3,792
BTAI icon
2409
BioXcel Therapeutics
BTAI
$24.8M
$22K ﹤0.01%
46
MDXG icon
2410
MiMedx Group
MDXG
$630M
$22K ﹤0.01%
3,604
RBBN icon
2411
Ribbon Communications
RBBN
$386M
$22K ﹤0.01%
3,680
RLMD icon
2412
Relmada Therapeutics
RLMD
$540M
$22K ﹤0.01%
840
CMRX
2413
DELISTED
Chimerix, Inc.
CMRX
$22K ﹤0.01%
3,551
AMK
2414
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$22K ﹤0.01%
885
CNBKA
2415
DELISTED
Century Bancorp Inc/Mass
CNBKA
$22K ﹤0.01%
190
INBX
2416
DELISTED
Inhibrx, Inc. Common Stock
INBX
$22K ﹤0.01%
662
AKBA icon
2417
Akebia Therapeutics
AKBA
$338M
$21K ﹤0.01%
7,428
ALTO icon
2418
Alto Ingredients
ALTO
$338M
$21K ﹤0.01%
4,244
ARKO icon
2419
ARKO Corp
ARKO
$868M
$21K ﹤0.01%
2,032
ATEN icon
2420
A10 Networks
ATEN
$2.07B
$21K ﹤0.01%
1,512
DGICA icon
2421
Donegal Group Class A
DGICA
$715M
$21K ﹤0.01%
1,483
DHIL
2422
DELISTED
Diamond Hill
DHIL
$21K ﹤0.01%
116
EGAN icon
2423
eGain
EGAN
$186M
$21K ﹤0.01%
2,042
FMBH icon
2424
First Mid Bancshares
FMBH
$1.4B
$21K ﹤0.01%
520
FOR icon
2425
Forestar Group
FOR
$1.48B
$21K ﹤0.01%
1,103

Similar funds

Canada Life's Q3 2021 Portfolio in Review

As of Q3 2021, Canada Life held 2,580 positions worth $43B, down 1.9% from $43.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 2.3%. Canada Life opened 18 new positions and exited 42, leaving the 2,580-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

  • Canada Life's largest Q3 2021 buy was UiPath: 421,792 shares worth $22.4M.
  • Canada Life added most to Electronic Arts in Q3 2021, an estimated $24.4M increase.
  • Canada Life's biggest Q3 2021 reduction was Alibaba, cutting an estimated $218M.
  • Canada Life fully exited GE Aerospace in Q3 2021, selling an estimated $94.2M.
  • Canada Life's ten largest holdings make up 21% of its $43B portfolio in Q3 2021.
  • Canada Life opened 18 new positions and closed 42 in Q3 2021.
  • Canada Life's portfolio value fell 1.9% quarter-over-quarter to $43B.

Based on Canada Life's 13F filing for Q3 2021, filed 15 Nov 2021.